| Year |
Citation |
Score |
| 2019 |
Beaulieu J, Borrelli E, Carlsson A, Caron MG, Civelli O, Espinoza S, Fisone G, Gainetdinov RR, Grandy DK, Kebabian JW, Langer SZ, Missale MC, Neve KA, Scatton B, Schwartz J, ... Sedvall G, et al. Dopamine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f20/2019.4 |
0.333 |
|
| 2008 |
Jönsson EG, Saetre P, Edman-Ahlbom B, Sillén A, Gunnar A, Andreou D, Agartz I, Sedvall G, Hall H, Terenius L. Brain-derived neurotrophic factor gene variation influences cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol concentrations in healthy volunteers. Journal of Neural Transmission (Vienna, Austria : 1996). 115: 1695-9. PMID 18781277 DOI: 10.1007/s00702-008-0113-9 |
0.307 |
|
| 2004 |
Jönsson EG, Bah J, Melke J, Abou Jamra R, Schumacher J, Westberg L, Ivo R, Cichon S, Propping P, Nöthen MM, Eriksson E, Sedvall GC. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Bmc Psychiatry. 4: 4. PMID 15102340 DOI: 10.1186/1471-244X-4-4 |
0.317 |
|
| 2004 |
Damberg M, Berggård C, Farde L, Sedvall GC, Jönsson EG. Transcription factor AP-2beta genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 537-45. PMID 15057523 DOI: 10.1007/s00702-003-0097-4 |
0.469 |
|
| 2003 |
Carmine A, Buervenich S, Galter D, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Chowdari KV, Nimgaonkar VL, Anvret M, Sydow O, Olson L. NURR1 promoter polymorphisms: Parkinson's disease, schizophrenia, and personality traits. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 120: 51-7. PMID 12815740 DOI: 10.1002/Ajmg.B.20033 |
0.373 |
|
| 2003 |
Jönsson EG, Sedvall GC, Nöthen MM, Cichon S. Dopamine D4 receptor gene (DRD4) variants and schizophrenia: meta-analyses. Schizophrenia Research. 61: 111-9. PMID 12648742 DOI: 10.1016/S0920-9964(02)00287-6 |
0.332 |
|
| 2003 |
Carmine A, Chheda MG, Jönsson EG, Sedvall GC, Farde L, Gustavsson JP, Bergman H, Anvret M, Buervenich S, Olson L. Two NOTCH4 polymorphisms and their relation to schizophrenia susceptibility and different personality traits. Psychiatric Genetics. 13: 23-8. PMID 12605097 DOI: 10.1097/01.ypg.0000056680.82896.22 |
0.436 |
|
| 2003 |
Hall H, Arnborg S, Agartz I, Sillén A, Jonsson E, Edman B, Nyman H, Terenius L, Sedvall G. P.2.114 Cross-domain analyses in schizophrenia — results from human brain informatics studies European Neuropsychopharmacology. 13: S330. DOI: 10.1016/S0924-977X(03)92067-0 |
0.301 |
|
| 2002 |
Karlsson P, Farde L, Halldin C, Sedvall G. PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. The American Journal of Psychiatry. 159: 761-7. PMID 11986129 DOI: 10.1176/Appi.Ajp.159.5.761 |
0.608 |
|
| 2002 |
Hall H, Arnborg S, Agartz I, Sedvall G. Data mining in schizophrenia in the Human Brain Informatics Project European Psychiatry. 17: 182. DOI: 10.1016/S0924-9338(02)80783-0 |
0.311 |
|
| 2002 |
Varnäs K, Hall H, Halldin C, Sedvall G. Autoradiographic localisation of 5-HT receptors in the human brain European Psychiatry. 17: 155. DOI: 10.1016/S0924-9338(02)80674-5 |
0.353 |
|
| 2002 |
Hall H, McNeil T, Arnborg S, Terenius L, Sedvall G. HUBIN — Human Brain Informatics: a database project on schizophrenia European Psychiatry. 17: 71. DOI: 10.1016/S0924-9338(02)80324-8 |
0.314 |
|
| 2001 |
Varnäs K, Hall H, Bonaventure P, Sedvall G. Autoradiographic mapping of 5-HT(1B) and 5-HT(1D) receptors in the post mortem human brain using [(3)H]GR 125743. Brain Research. 915: 47-57. PMID 11578619 DOI: 10.1016/S0006-8993(01)02823-2 |
0.386 |
|
| 2001 |
Jönsson EG, Ivo R, Forslund K, Mattila-Evenden M, Rylander G, Cichon S, Propping P, Nöthen MM, Asberg M, Sedvall GC. No association between a promoter dopamine D(4) receptor gene variant and schizophrenia. American Journal of Medical Genetics. 105: 525-8. PMID 11496369 DOI: 10.1002/ajmg.1478 |
0.309 |
|
| 2001 |
Nobuhara K, Farde L, Halldin C, Karlsson P, Swahn CG, Olsson H, Bergström KA, Larsson SA, Schnell PO, McPherson DW, Savonen A, Hiltunen J, Sedvall G. SPET imaging of central muscarinic acetylcholine receptors with iodine-123 labelled E-IQNP and Z-IQNP. European Journal of Nuclear Medicine. 28: 13-24. PMID 11202446 DOI: 10.1007/S002590000390 |
0.495 |
|
| 2001 |
Hall H, Hurd Y, Pauli S, Halldin C, Sedvall G. Human brain imaging post-mortem - Whole hemisphere technologies International Review of Psychiatry. 13: 12-17. DOI: 10.1080/09540260124940 |
0.427 |
|
| 2001 |
Hall H, Varnäs K, Werner T, Stenfors C, Sedvall G. Autoradiographic studies of the 5-HT1B/D receptors in the postmortem human brain using [3H]AR-A000002; Comparison with [3H]GR125743 European Neuropsychopharmacology. 11: S216. DOI: 10.1016/S0924-977X(01)80203-0 |
0.364 |
|
| 2000 |
Hall H, Farde L, Halldin C, Lundkvist C, Sedvall G. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907. Synapse (New York, N.Y.). 38: 421-31. PMID 11044889 DOI: 10.1002/1098-2396(20001215)38:4<421::Aid-Syn7>3.0.Co;2-X |
0.525 |
|
| 2000 |
Nobuhara K, Halldin C, Hall H, Karlsson P, Farde L, Hiltunen J, McPherson DW, Savonen A, Bergström KA, Pauli S, Swahn CG, Larsson SA, Schnell PO, Sedvall G. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer's disease. Psychopharmacology. 149: 45-55. PMID 10789882 DOI: 10.1007/S002139900356 |
0.534 |
|
| 1999 |
Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden M, Asberg M, Propping P, Sedvall GC. Association between a promoter polymorphism in the dopamine D2 receptor gene and schizophrenia. Schizophrenia Research. 40: 31-6. PMID 10541004 DOI: 10.1016/S0920-9964(99)00033-X |
0.333 |
|
| 1999 |
Jönsson EG, Nöthen MM, Grünhage F, Farde L, Nakashima Y, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry. 4: 290-6. PMID 10395223 DOI: 10.1038/Sj.Mp.4000532 |
0.554 |
|
| 1999 |
Sandell J, Halldin C, Hall H, Thorberg SO, Werner T, Sohn D, Sedvall G, Farde L. Radiosynthesis and autoradiographic evaluation of [11C]NAD-299, a radioligand for visualization of the 5-HT1A receptor. Nuclear Medicine and Biology. 26: 159-64. PMID 10100214 DOI: 10.1016/S0969-8051(98)00091-2 |
0.563 |
|
| 1999 |
Hall H, Halldin C, Guilloteau D, Chalon S, Emond P, Besnard J, Farde L, Sedvall G. Visualization of the dopamine transporter in the human brain postmortem with the new selective ligand [125I]PE2I. Neuroimage. 9: 108-16. PMID 9918732 DOI: 10.1006/Nimg.1998.0366 |
0.553 |
|
| 1999 |
Pauli S, Hall H, Halldin C, Hurd Y, Sedvall G. Spatial visualization and relative quantification of D2- dopamine receptors in a human post mortem brain hemisphere European Neuropsychopharmacology. 9: 355. DOI: 10.1016/S0924-977X(99)80537-9 |
0.449 |
|
| 1999 |
Sedvall GC, Karlsson P. Pharmacological manipulation of D1-dopamine receptor function in schizophrenia Neuropsychopharmacology. 21: S181-S188. DOI: 10.1016/S0893-133X(99)00104-9 |
0.347 |
|
| 1998 |
Halldin C, Foged C, Chou YH, Karlsson P, Swahn CG, Sandell J, Sedvall G, Farde L. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 39: 2061-8. PMID 9867142 |
0.593 |
|
| 1998 |
Hall H, Halldin C, Farde L, Sedvall G. Whole hemisphere autoradiography of the postmortem human brain. Nuclear Medicine and Biology. 25: 715-9. PMID 9863555 DOI: 10.1016/S0969-8051(98)00053-5 |
0.573 |
|
| 1998 |
Caberlotto L, Fuxe K, Rimland JM, Sedvall G, Hurd YL. Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain. Neuroscience. 86: 167-78. PMID 9692752 DOI: 10.1016/S0306-4522(98)00039-6 |
0.351 |
|
| 1998 |
Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Research. 779: 58-74. PMID 9473588 DOI: 10.1016/S0006-8993(97)01078-0 |
0.429 |
|
| 1998 |
Hall H, Halldin C, Farde L, Sedvall G. Distribution of Serotonin Receptor Subtypes in the Post-Mortem Human Brain Neuroimage. 7: S291. DOI: 10.1016/S1053-8119(18)31124-8 |
0.492 |
|
| 1998 |
Hall H, Halldin C, Sandell J, Werner T, Thorberg O, Sedvall G. Autoradiographic studies of the labelling of 5-HT1A receptors in the post-mortem human brain using [11C]NAD-299 and [3H]NAD-299 European Neuropsychopharmacology. 8: S170. DOI: 10.1016/S0924-977X(98)80219-8 |
0.395 |
|
| 1998 |
Jönsson EG, Nöthen MM, Neidt H, Farde L, Propping P, Sedvall GC. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density in vivo of healthy volunteers American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 497. |
0.36 |
|
| 1998 |
Jönsson EG, Nöthen MM, Neidt H, Forslund K, Rylander G, Mattila-Evenden MM, Åsberg M, Propping P, Sedvall GC. Association between a promoter poly-morphism in the dopamine D2 receptor gene and schizophrenia American Journal of Medical Genetics - Neuropsychiatric Genetics. 81: 497. |
0.327 |
|
| 1997 |
Svenningsson P, Hall H, Sedvall G, Fredholm BB. Distribution of adenosine receptors in the postmortem human brain: an extended autoradiographic study. Synapse (New York, N.Y.). 27: 322-35. PMID 9372555 DOI: 10.1002/(SICI)1098-2396(199712)27:4<322::AID-SYN6>3.0.CO;2-E |
0.632 |
|
| 1997 |
Günther I, Hall H, Halldin C, Swahn CG, Farde L, Sedvall G. [125I] beta-CIT-FE and [125I] beta-CIT-FP are superior to [125I] beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain. Nuclear Medicine and Biology. 24: 629-34. PMID 9352533 DOI: 10.1016/S0969-8051(97)00081-4 |
0.464 |
|
| 1997 |
Hall H, Halldin C, Jerning E, Osterlund M, Farde L, Sedvall G. Autoradiographic comparison of [125I]epidepride and [125I]NCQ 298 binding to human brain extrastriated dopamine receptors. Nuclear Medicine and Biology. 24: 389-93. PMID 9290072 DOI: 10.1016/S0969-8051(97)80004-2 |
0.612 |
|
| 1997 |
Caberlotto L, Fuxe K, Sedvall G, Hurd YL. Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum. The European Journal of Neuroscience. 9: 1212-25. PMID 9215705 DOI: 10.1111/J.1460-9568.1997.Tb01476.X |
0.385 |
|
| 1997 |
Pauli S, Sedvall G. Three-dimensional visualization and quantification of the benzodiazepine receptor population within a living human brain using PET and MRI. European Archives of Psychiatry and Clinical Neuroscience. 247: 61-70. PMID 9177951 DOI: 10.1007/Bf02900195 |
0.414 |
|
| 1997 |
Ginovart N, Lundin A, Farde L, Halldin C, Bäckman L, Swahn CG, Pauli S, Sedvall G. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain : a Journal of Neurology. 120: 503-14. PMID 9126061 DOI: 10.1093/Brain/120.3.503 |
0.603 |
|
| 1997 |
Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, Fletcher A, Cliffe IA, Barf T, Wikström H, Sedvall G. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Research. 745: 96-108. PMID 9037397 DOI: 10.1016/S0006-8993(96)01131-6 |
0.582 |
|
| 1997 |
Sedvall G. Dopamine D2 receptor imaging of antipsychotic drug action Psychiatry Research: Neuroimaging. 68: 176. DOI: 10.1016/S0925-4927(97)81574-0 |
0.33 |
|
| 1997 |
Sedvall G. What is wrong with dopamine receptors in schizophrenia Psychiatry Research: Neuroimaging. 68: 176. DOI: 10.1016/S0925-4927(97)81573-9 |
0.323 |
|
| 1997 |
Pauli S, Hall H, Halldin C, Sedvall G. Neuro-receptor imaging in threedimensions in vivo and in vitro: Application to dopamine and benzodiazepine receptors Schizophrenia Research. 24: 180. DOI: 10.1016/S0920-9964(97)82518-2 |
0.43 |
|
| 1997 |
Karlsson P, Farde L, Halldin C, Sedvall G. D1-Dopamine receptors in schizophrenia examined by pet Schizophrenia Research. 24: 178-179. DOI: 10.1016/S0920-9964(97)82513-3 |
0.608 |
|
| 1996 |
Oxenstierna G, Bergstrand G, Edman G, Flyckt L, Nybäck H, Sedvall G. Increased frequency of aberrant CSF circulation in schizophrenic patients compared to healthy volunteers. European Psychiatry : the Journal of the Association of European Psychiatrists. 11: 16-20. PMID 19698417 DOI: 10.1016/0924-9338(96)80454-8 |
0.301 |
|
| 1996 |
Hall H, Halldin C, Dijkstra D, Wikström H, Wise LD, Pugsley TA, Sokoloff P, Pauli S, Farde L, Sedvall G. Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907. Psychopharmacology. 128: 240-7. PMID 8972543 DOI: 10.1007/S002130050131 |
0.59 |
|
| 1996 |
Jönsson E, Sedvall G, Brené S, Gustavsson JP, Geijer T, Terenius L, Crocq MA, Lannfelt L, Tylec A, Sokoloff P, Schwartz JC, Wiesel FA. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biological Psychiatry. 40: 1032-43. PMID 8915563 DOI: 10.1016/0006-3223(95)00581-1 |
0.395 |
|
| 1996 |
Jönsson E, Brené S, Geijer T, Terenius L, Tylec A, Persson ML, Sedvall G. A search for association between schizophrenia and dopamine-related alleles. European Archives of Psychiatry and Clinical Neuroscience. 246: 297-304. PMID 8908411 DOI: 10.1007/BF02189022 |
0.437 |
|
| 1996 |
Sedvall GC. Neurobiological correlates of acute neuroleptic treatment. International Clinical Psychopharmacology. 11: 41-6. PMID 8803659 DOI: 10.1097/00004850-199605002-00007 |
0.325 |
|
| 1996 |
Hall H, Farde L, Halldin C, Hurd YL, Pauli S, Sedvall G. Autoradiographic localization of extrastriatal D2-dopamine receptors in the human brain using [125I]epidepride. Synapse (New York, N.Y.). 23: 115-23. PMID 8723716 DOI: 10.1002/(Sici)1098-2396(199606)23:2<115::Aid-Syn7>3.0.Co;2-C |
0.617 |
|
| 1996 |
Sedvall G, Farde L. Dopamine receptors in schizophrenia. Lancet. 347: 264. PMID 8551909 DOI: 10.1016/S0140-6736(96)90440-7 |
0.578 |
|
| 1996 |
NORDSTRÖM A, FARDE L, NYBERG S, KARLSSON P, HALLDIN C, SEDVALL G. Dr. Nordström and Colleagues Reply American Journal of Psychiatry. 153: 1240-1240. DOI: 10.1176/Ajp.153.9.1240 |
0.407 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. Reduced D1-dopamine receptor binding in schizophrenia — Relation to psychopathology European Neuropsychopharmacology. 6: 212-213. DOI: 10.1016/0924-977X(96)88301-5 |
0.601 |
|
| 1996 |
Hall H, Lundkvist C, Halldin C, Pike V, McCarron J, Fletcher A, Cliffe I, Farde L, Sedvall G. Autoradiographic localization of 5-HT1A-receptors in the human brain European Neuropsychopharmacology. 6: 212. DOI: 10.1016/0924-977X(96)88297-6 |
0.548 |
|
| 1996 |
Hall H, Hurd Y, Suzuki M, Farde L, Halldin C, Sedvall G. Distribution of dopamine receptor subtypes in the post-mortem human brain European Neuropsychopharmacology. 6: 157. DOI: 10.1016/0924-977X(96)88033-3 |
0.6 |
|
| 1996 |
Ginovart N, Lundin A, Farde L, Halldin C, Swahn C, Pauli S, Sedvall G. In vivo examination of the Pre- and postsynaptic dopamine neurons in huntington's disease European Neuropsychopharmacology. 6: 130. DOI: 10.1016/0924-977X(96)87905-3 |
0.492 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. PET D1-receptor studies in schizophrenia European Psychiatry. 11: 231s-232s. DOI: 10.1016/0924-9338(96)88691-3 |
0.566 |
|
| 1996 |
Karlsson P, Farde L, Halldin C, Sedvall G. Decrease of D1-dopamine receptor binding in the frontal cortex of neuroleptic naive schizophrenic patients measured by PET Schizophrenia Research. 18: 198. DOI: 10.1016/0920-9964(96)85618-0 |
0.609 |
|
| 1995 |
Sedvall G, Pauli S, Karlsson P, Farde L, Nordström AL, Nyberg S, Halldin C. PET imaging of neuroreceptors in schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 25-30. PMID 8775755 DOI: 10.1016/0924-977X(95)00021-G |
0.648 |
|
| 1995 |
Karlsson P, Smith L, Farde L, Härnryd C, Sedvall G, Wiesel FA. Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients. Psychopharmacology. 121: 309-16. PMID 8584611 DOI: 10.1007/BF02246068 |
0.533 |
|
| 1995 |
Karlsson P, Sedvall G, Halldin C, Swahn CG, Farde L. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man. Psychopharmacology. 121: 300-8. PMID 8584610 DOI: 10.1007/Bf02246067 |
0.641 |
|
| 1995 |
Karlsson P, Farde L, Halldin C, Sedvall G, Ynddal L, Sloth-Nielsen M. Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man. Psychopharmacology. 119: 1-8. PMID 7675940 DOI: 10.1007/Bf02246046 |
0.613 |
|
| 1995 |
Sedvall G, Farde L. Chemical brain anatomy in schizophrenia. Lancet. 346: 743-9. PMID 7658878 DOI: 10.1016/S0140-6736(95)91508-7 |
0.418 |
|
| 1995 |
Sedvall G, Pauli S, Farde L, Karlsson P, Nyberg S, Nordström AL. Recent developments in PET scan imaging of neuroreceptors in schizophrenia. The Israel Journal of Psychiatry and Related Sciences. 32: 22-9. PMID 7622344 |
0.591 |
|
| 1995 |
Sedvall G, Farde L, Hall H, Halldin C, Karlsson P, Nordström AL, Nyberg S, Pauli S. Utilization of radioligands in schizophrenia research. Clinical Neuroscience (New York, N.Y.). 3: 112-21. PMID 7583617 |
0.592 |
|
| 1995 |
Nordström AL, Farde L, Nyberg S, Karlsson P, Halldin C, Sedvall G. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients. The American Journal of Psychiatry. 152: 1444-9. PMID 7573582 DOI: 10.1176/Ajp.152.10.1444 |
0.582 |
|
| 1995 |
Hall H, Halldin C, Nyberg S, Farde L, Sedvall G. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 5: 19-25. PMID 7542051 DOI: 10.1016/0924-977X(94)00127-W |
0.632 |
|
| 1995 |
Brené S, Hall H, Lindefors N, Karlsson P, Halldin C, Sedvall G. Distribution of messenger RNAs for D1 dopamine receptors and DARPP-32 in striatum and cerebral cortex of the cynomolgus monkey: relationship to D1 dopamine receptors. Neuroscience. 67: 37-48. PMID 7477907 DOI: 10.1016/0306-4522(95)00037-J |
0.442 |
|
| 1995 |
Jönsson E, Sedvall G, Brene S, Gustafsson JP, Geijer T, Terenius L, Crocq M-, Lannfelt L, Sokoloff P, Schwartz JC, Wiesel F-. Relationships between cerebrospinal fluid monoamine metabolites and dopamine-related genotypes in healthy volunteers Psychiatric Genetics. 5: 135. DOI: 10.1097/00041444-199505030-00018 |
0.361 |
|
| 1995 |
Farde L, Nordström A, Karlsson P, Halldin C, Sedvall G. Positron Emission Tomography Studies on Dopamine Receptors in Schizophrenia Clinical Neuropharmacology. 18: S121-S129. DOI: 10.1097/00002826-199501001-00014 |
0.582 |
|
| 1995 |
HALL H, FARDE L, HALLDIN C, NYBERG S, MOHELL N, JACKSON D, SEDVALL G. Extra-striatal dopamine receptors studied with [125I]epideprideIn VITRO and [[11C]FLB 457in vivo Pharmacological Research. 31: 29-29. DOI: 10.1016/1043-6618(95)86377-X |
0.544 |
|
| 1995 |
Hall H, Halldin C, Suzuki M, Dijkstra D, Wikström H, Wise L, Pugsley T, Hurd Y, Farde L, Pauli S, Sedvall G. P-4-61 Autoradiographic comparison of D2- and D3-dopamine receptor localization in the post mortem human brain using [125I]epidepride and [3H]PD 128907 European Neuropsychopharmacology. 5: 346. DOI: 10.1016/0924-977X(95)90581-W |
0.577 |
|
| 1995 |
Karlsson P, Farde L, Halldin C, Sedvall G. Decreased D1-dopamine receptor binding in drug naive schizophrenic patients examined by pet Schizophrenia Research. 15: 86. DOI: 10.1016/0920-9964(95)95267-D |
0.619 |
|
| 1995 |
Farde L, Nordstrom AL, Karlsson P, Halldin C, Sedvall G, Sethy, Schwartz JC, Von Voigtlander. Positron emission tomography studies on dopamine receptors in schizophrenia Clinical Neuropharmacology. 18: S121-S129. |
0.329 |
|
| 1994 |
Sedvall G, Karlsson P, Lundin A, Anvret M, Suhara T, Halldin C, Farde L. Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease. European Archives of Psychiatry and Clinical Neuroscience. 243: 249-55. PMID 8172940 DOI: 10.1007/Bf02191583 |
0.633 |
|
| 1994 |
Brené S, Lindefors N, Ehrlich M, Taubes T, Horiuchi A, Kopp J, Hall H, Sedvall G, Greengard P, Persson H. Expression of mRNAs encoding ARPP-16/19, ARPP-21, and DARPP-32 in human brain tissue. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 985-98. PMID 8120638 DOI: 10.1523/Jneurosci.14-03-00985.1994 |
0.327 |
|
| 1994 |
Farde L, Pauli S, Litton JE, Halldin C, Neiman J, Sedvall G. PET-determination of benzodiazepine receptor binding in studies on alcoholism. Exs. 71: 143-53. PMID 8032146 |
0.479 |
|
| 1994 |
Farde L, Nordström AL, Nyberg S, Halldin C, Sedvall G. D1-, D2-, and 5-HT2-receptor occupancy in clozapine-treated patients. The Journal of Clinical Psychiatry. 55: 67-9. PMID 7961577 |
0.535 |
|
| 1994 |
Sedvall G. [Image processing in psychiatry--a review]. Fortschritte Der Neurologie-Psychiatrie. 62: 39-43. PMID 7959526 |
0.366 |
|
| 1994 |
Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 11: 245-56. PMID 7531978 DOI: 10.1038/Sj.Npp.1380111 |
0.637 |
|
| 1994 |
Swahn C, Halldin C, Farde L, Sedvall G. Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLC Human Psychopharmacology: Clinical and Experimental. 9: 25-31. DOI: 10.1002/Hup.470090103 |
0.503 |
|
| 1994 |
Swahn CG, Halldin C, Farde L, Karlsson P, Sedvall G. Metabolism in human plasma determined by HPLC for five 11C-labelled benzazepines-radioligands for PET examination of the dopamine D-1 receptor Journal of Labelled Compounds and Radiopharmaceuticals. 35: 540-542. |
0.358 |
|
| 1994 |
Halidin C, Swahn CG, Suhara T, Farde L, Karlsson P, Sokoloff P, Sedvall G. Preparation of (+)-[propyl-11C]7-OH-DPAT, a selective dopamine D-3 receptor agonist for PET Journal of Labelled Compounds and Radiopharmaceuticals. 35: 471-472. |
0.383 |
|
| 1993 |
Jönsson E, Lannfelt L, Sokoloff P, Schwartz JC, Sedvall G. Lack of association between schizophrenia and alleles in the dopamine D3 receptor gene. Acta Psychiatrica Scandinavica. 87: 345-9. PMID 8517175 DOI: 10.1111/J.1600-0447.1993.Tb03384.X |
0.447 |
|
| 1993 |
Hall H, Halldin C, Sedvall G. Binding of [3H]SCH 39166 to human post mortem brain tissue. Pharmacology & Toxicology. 72: 152-8. PMID 8516265 DOI: 10.1111/J.1600-0773.1993.Tb00308.X |
0.393 |
|
| 1993 |
Litton JE, Neiman J, Pauli S, Farde L, Hindmarsh T, Halldin C, Sedvall G. PET analysis of [11C]flumazenil binding to benzodiazepine receptors in chronic alcohol-dependent men and healthy controls. Psychiatry Research. 50: 1-13. PMID 8390063 DOI: 10.1016/0925-4927(93)90019-E |
0.541 |
|
| 1993 |
Halldin C, Foged C, Farde L, Karlsson P, Hansen K, Grønvald F, Swahn CG, Hall H, Sedvall G. [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkey. Nuclear Medicine and Biology. 20: 945-53. PMID 8298574 DOI: 10.1016/0969-8051(93)90095-C |
0.607 |
|
| 1993 |
Karlsson P, Farde L, Halldin C, Swahn CG, Sedvall G, Foged C, Hansen KT, Skrumsager B. PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptor. Psychopharmacology. 113: 149-56. PMID 7855175 DOI: 10.1007/Bf02245691 |
0.622 |
|
| 1992 |
Hall H, Halldin C, Sedvall G. Gpp(NH)p stimulates [3H]raclopride binding to homogenates from human putamen and accumbens. Neuroscience Letters. 136: 79-82. PMID 1635671 DOI: 10.1016/0304-3940(92)90652-N |
0.445 |
|
| 1992 |
Kopp J, Lindefors N, Brené S, Hall H, Persson H, Sedvall G. Effect of raclopride on dopamine D2 receptor mRNA expression in rat brain. Neuroscience. 47: 771-9. PMID 1533704 DOI: 10.1016/0306-4522(92)90028-Z |
0.483 |
|
| 1992 |
Sedvall G. The current status of PET scanning with respect to schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 7: 41-54. PMID 1388021 |
0.411 |
|
| 1992 |
Hall H, Farde L, Halldin C, Högberg T, Larsson S, Sedvall G. Imaging of dopamine receptors using PET and SPECT. Neurochemistry International. 20: 329S-333S. PMID 1365450 DOI: 10.1016/0197-0186(92)90260-X |
0.578 |
|
| 1992 |
Farde L, Nordström AL, Halldin C, Wiesel FA, Sedvall G. PET studies of dopamine receptors in relation to antipsychotic drug treatment. Clinical Neuropharmacology. 15: 468A-469A. PMID 1354052 |
0.532 |
|
| 1992 |
Farde L, Nordström AL, Wiesel FA, Pauli S, Halldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. Archives of General Psychiatry. 49: 538-44. PMID 1352677 DOI: 10.1001/Archpsyc.1992.01820070032005 |
0.558 |
|
| 1992 |
Halldin C, Farde L, Litton JE, Hall H, Sedvall G. [11C]Ro 15-4513, a ligand for visualization of benzodiazepine receptor binding. Preparation, autoradiography and positron emission tomography. Psychopharmacology. 108: 16-22. PMID 1329130 DOI: 10.1007/Bf02245279 |
0.576 |
|
| 1992 |
Pauli S, Liljequist S, Farde L, Swahn CG, Halldin C, Litton JE, Sedvall G. PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil. Psychopharmacology. 107: 180-5. PMID 1319600 DOI: 10.1007/Bf02245135 |
0.529 |
|
| 1992 |
Lannfelt L, Sokoloff P, Martres M, Pilon C, Giros B, Jönsson E, Sedvall G, Schwartz J. Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disorders Psychiatric Genetics. 2: 249-256. DOI: 10.1097/00041444-199210000-00003 |
0.478 |
|
| 1992 |
SEDVALL G, FARDE L, NORDSTROM A. PET SCANNING OF DOPAMINE RECEPTORS AND PSYCHOSIS Behavioural Pharmacology. 3: 21. DOI: 10.1097/00008877-199204001-00061 |
0.602 |
|
| 1992 |
Lindefors N, Brené S, Kopp J, Hall H, Persson H, Sedvall G. NEUROLEPTIC TREATMENT AND DOPAMINE LESIONS MODULATE POST-SYNAPTIC EXPRESSION OF DOPAMINE D2 RECEPTOR mRNA IN RAT BRAIN. Clinical Neuropharmacology. 15: 131B. DOI: 10.1097/00002826-199202001-00251 |
0.429 |
|
| 1992 |
Hall H, Farde L, Litton JE, Halldin C, Sedvall G. PET AND AUTORADIOGRAPHY OF BENZODIAZEPINE RECEPTOR BINDING WITH RADIOLABELLED FLUMAZENIL AND RO 15-4513. Clinical Neuropharmacology. 15: 29B. DOI: 10.1097/00002826-199202001-00054 |
0.549 |
|
| 1992 |
Swahn CG, Farde L, Halldin C, Sedvall G. Ligand metabolites in plasma during PET-studies with the 11C-labelled dopamine antagonists, raclopride, SCH 23390 and N-methylspiroperidol Human Psychopharmacology. 7: 97-103. DOI: 10.1002/Hup.470070204 |
0.511 |
|
| 1991 |
Persson A, d'Argy R, Gillberg PG, Halldin C, Litton JE, Swahn CG, Sedvall G. Autoradiography with saturation experiments of 11C-Ro 15-1788 binding to human brain sections. Journal of Neuroscience Methods. 36: 53-61. PMID 2062111 DOI: 10.1016/0165-0270(91)90137-O |
0.387 |
|
| 1991 |
Sedvall G, Farde L, Barnett A, Hall H, Halldin C. 11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET. Psychopharmacology. 103: 150-3. PMID 1674157 DOI: 10.1007/Bf02244195 |
0.648 |
|
| 1991 |
Halldin C, Farde L, Hall H, Högberg T, Printz G, Pulka W, Sedvall G, Solin O. Synthesis of five benzamide analogs. Comparison with positron emission tomography. Acta Radiologica. Supplementum. 376: 121-2. PMID 1666743 |
0.379 |
|
| 1991 |
Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigations. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 42: 451-5. PMID 1646191 DOI: 10.1016/0883-2889(91)90105-A |
0.605 |
|
| 1991 |
Pauli S, Farde L, Halldin C, Sedvall G. Occupancy of the central benzodiazepine receptors during benzodiazepine treatment determined by PET European Neuropsychopharmacology. 1: 229-231. DOI: 10.1016/0924-977X(91)90498-J |
0.54 |
|
| 1991 |
Halldin C, Farde L, Barnett A, Sedvall G. Synthesis of [11C]SCH 39166, a new selective D-1 dopamine receptor ligand for PET Journal of Labelled Compounds and Radiopharmaceuticals. 30: 349 -350. |
0.364 |
|
| 1990 |
Halldin C, Farde L, Högberg T, Hall H, Sedvall G. Carbon-11 labelling of eticlopride in two different positions--a selective high-affinity ligand for the study of dopamine D-2 receptors using PET. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 41: 669-74. PMID 2170298 DOI: 10.1016/0883-2889(90)90082-R |
0.586 |
|
| 1990 |
Kopp J, Hall H, Persson A, Sedvall G. Temperature dependence of [3H]Ro 15-1788 binding to benzodiazepine receptors in human postmortem brain homogenates. Journal of Neurochemistry. 55: 1310-5. PMID 2168936 DOI: 10.1111/J.1471-4159.1990.Tb03140.X |
0.356 |
|
| 1990 |
Wiesel FA, Farde L, Nordström AL, Sedvall G. Central D1- and D2-receptor occupancy during antipsychotic drug treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 14: 759-67. PMID 1981395 DOI: 10.1016/0278-5846(90)90046-J |
0.613 |
|
| 1990 |
Sedvall G. Monoamines and schizophrenia. Acta Psychiatrica Scandinavica. Supplementum. 358: 7-13. PMID 1978495 DOI: 10.1111/J.1600-0447.1990.Tb05279.X |
0.492 |
|
| 1990 |
Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordström AL, Hall H, Sedvall G. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Archives of General Psychiatry. 47: 213-9. PMID 1968328 DOI: 10.1001/Archpsyc.1990.01810150013003 |
0.647 |
|
| 1990 |
Sedvall G, Farde L, Nybäck H, Pauli S, Persson A, Savic I, Wiesel FA. Recent advances in psychiatric brain imaging. Acta Radiologica. Supplementum. 374: 113-5. PMID 1966956 |
0.428 |
|
| 1990 |
Sedvall G. PET imaging of dopamine receptors in human basal ganglia: relevance to mental illness. Trends in Neurosciences. 13: 302-8. PMID 1695408 DOI: 10.1016/0166-2236(90)90114-P |
0.43 |
|
| 1990 |
Farde L, Nordstrom A, Wiesel F, Halldin C, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with classical and atypical neurpleptics Schizophrenia Research. 3: 51-52. DOI: 10.1016/0920-9964(90)90133-R |
0.582 |
|
| 1989 |
Farde L, Wiesel FA, Nilsson L, Sedvall G. The potential of positron-emission tomography for pharmacokinetic and pharmacodynamic studies of neuroleptics. Psychopharmacology Series. 7: 32-9. PMID 2574454 DOI: 10.1007/978-3-642-74430-3_4 |
0.403 |
|
| 1989 |
Sedvall G. Approaches for finding new types of antipsychotic compounds. Acta Psychiatrica Scandinavica. Supplementum. 352: 16-23. PMID 2573237 DOI: 10.1111/J.1600-0447.1989.Tb06431.X |
0.394 |
|
| 1989 |
Farde L, Wiesel FA, Nordström AL, Sedvall G. D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics. Psychopharmacology. 99: S28-31. PMID 2573104 DOI: 10.1007/BF00442555 |
0.614 |
|
| 1989 |
Walaas SI, Sedvall G, Greengard P. Dopamine-regulated phosphorylation of synaptic vesicle-associated proteins in rat neostriatum and substantia nigra. Neuroscience. 29: 9-19. PMID 2496331 DOI: 10.1016/0306-4522(89)90328-X |
0.365 |
|
| 1989 |
Persson A, Pauli S, Swahn CG, Halldin C, Sedvall G. Cerebral uptake of 11C—Ro 15—1788 and its acid metabolite 11C—Ro 15—3890; PET study in healthy volunteers Human Psychopharmacology-Clinical and Experimental. 4: 215-220. DOI: 10.1002/Hup.470040307 |
0.36 |
|
| 1989 |
Persson A, Pauli S, Halldin C, Stone-Elander S, Farde L, Sjögren I, Sedvall G. Saturation analysis of specific11C Ro 15-1788 binding to the human neocortex using positron emission tomography Human Psychopharmacology: Clinical and Experimental. 4: 21-31. DOI: 10.1002/Hup.470040105 |
0.583 |
|
| 1989 |
Farde L, Wiesel FA, Halldin C, Sedvall G, Nilsson L. Dopamine Receptor Occupancy and Plasma Haloperidol Levels-Reply Archives of General Psychiatry. 46: 483-484. DOI: 10.1001/Archpsyc.1989.01810050097022 |
0.575 |
|
| 1988 |
Farde L, Wiesel FA, Jansson P, Uppfeldt G, Wahlen A, Sedvall G. An open label trial of raclopride in acute schizophrenia. Confirmation of D2-dopamine receptor occupancy by PET. Psychopharmacology. 94: 1-7. PMID 3126517 DOI: 10.1007/BF00735871 |
0.621 |
|
| 1988 |
Sedvall G, Farde L, Hall H, Pauli S, Persson A, Wiesel FA. PET scanning--a new tool in clinical psychopharmacology. Psychopharmacology Series. 5: 27-33. PMID 3045802 DOI: 10.1007/978-3-642-73280-5_3 |
0.65 |
|
| 1988 |
Hall H, Köhler C, Gawell L, Farde L, Sedvall G. Raclopride, a new selective ligand for the dopamine-D2 receptors. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 12: 559-68. PMID 2975809 DOI: 10.1016/0278-5846(88)90001-2 |
0.641 |
|
| 1988 |
Andreasen NC, Carson R, Diksic M, Evans A, Farde L, Gjedde A, Hakim A, Lal S, Nair N, Sedvall G. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum. Schizophrenia Bulletin. 14: 471-84. PMID 2975043 DOI: 10.1093/SCHBUL/14.3.471 |
0.592 |
|
| 1988 |
Hall H, Farde L, Sedvall G. Human dopamine receptor subtypes--in vitro binding analysis using 3H-SCH 23390 and 3H-raclopride. Journal of Neural Transmission. 73: 7-21. PMID 2969950 DOI: 10.1007/BF01244618 |
0.632 |
|
| 1988 |
Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widén L. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet (London, England). 2: 863-6. PMID 2902315 DOI: 10.1016/S0140-6736(88)92468-3 |
0.431 |
|
| 1988 |
Farde L, Grind M, Nilsson MI, Ogenstad S, Sedvall G. Remoxipride--a new potential antipsychotic drug. Pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers. Psychopharmacology. 95: 157-61. PMID 2901121 DOI: 10.1007/BF00174501 |
0.458 |
|
| 1988 |
Farde L, Wiesel FA, Halldin C, Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Archives of General Psychiatry. 45: 71-6. PMID 2892477 DOI: 10.1001/Archpsyc.1988.01800250087012 |
0.609 |
|
| 1987 |
Lindvall O, Backlund EO, Farde L, Sedvall G, Freedman R, Hoffer B, Nobin A, Seiger A, Olson L. Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Annals of Neurology. 22: 457-68. PMID 3435067 DOI: 10.1002/Ana.410220403 |
0.464 |
|
| 1987 |
d'Argy R, Persson A, Sedvall G. A quantitative cerebral and whole body autoradiographic study of a intravenously administered benzodiazepine antagonist 3H-Ro 15-1788 in mice. Psychopharmacology. 92: 8-13. PMID 3037585 DOI: 10.1007/BF00215472 |
0.337 |
|
| 1987 |
Farde L, Halldin C, Stone-Elander S, Sedvall G. PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopride. Psychopharmacology. 92: 278-84. PMID 2957716 DOI: 10.1007/Bf00210831 |
0.638 |
|
| 1987 |
Sedvall G, Farde L, Wiesel FA. Quantitative determination of D2 dopamine receptor characteristics in healthy human subjects and psychiatric patients. Life Sciences. 41: 813-6. PMID 2956473 DOI: 10.1016/0024-3205(87)90169-X |
0.598 |
|
| 1987 |
Farde L, Wiesel FA, Hall H, Halldin C, Stone-Elander S, Sedvall G. No D2 receptor increase in PET study of schizophrenia. Archives of General Psychiatry. 44: 671-2. PMID 2955770 DOI: 10.1001/Archpsyc.1987.01800190091013 |
0.61 |
|
| 1987 |
Sedvall G, Nybäck H, Farde L, Persson A. Neurotransmitter receptor imaging in Alzheimer's disease. Journal of Neural Transmission. Supplementum. 24: 43-8. PMID 2824693 |
0.35 |
|
| 1987 |
Sedvall G, Ehrin E, Farde L. Stereoselective binding of11C-labelled piquindone (Ro 22-1319) to dopamine-D2 receptors in the living human brain Human Psychopharmacology: Clinical and Experimental. 2: 23-30. DOI: 10.1002/HUP.470020105 |
0.649 |
|
| 1986 |
Nock B, Sedvall G, Mcewen BS. Quantitative autoradiography of [3H]piquindone binding sites (dopamine D2 receptors) in rat brain. European Journal of Pharmacology. 121: 387-93. PMID 3699100 DOI: 10.1016/0014-2999(86)90259-1 |
0.413 |
|
| 1986 |
Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Långström B, Sedvall G. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. International Journal of Radiation Applications and Instrumentation. Part a, Applied Radiation and Isotopes. 37: 1039-43. PMID 3027000 DOI: 10.1016/0883-2889(86)90044-4 |
0.591 |
|
| 1986 |
Sedvall G, Farde L, Persson A, Wiesel FA. Imaging of neurotransmitter receptors in the living human brain. Archives of General Psychiatry. 43: 995-1005. PMID 3019270 DOI: 10.1001/Archpsyc.1986.01800100089012 |
0.534 |
|
| 1986 |
Sedvall G, Farde L, Stone-Elander S, Halldin C. Dopamine D1-receptor binding in the living human brain. Advances in Experimental Medicine and Biology. 204: 119-24. PMID 2947423 DOI: 10.1007/978-1-4684-5191-7_7 |
0.631 |
|
| 1986 |
Farde L, Hall H, Ehrin E, Sedvall G. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. Science (New York, N.Y.). 231: 258-61. PMID 2867601 DOI: 10.1126/SCIENCE.2867601 |
0.643 |
|
| 1985 |
Ehrin E, Farde L, de Paulis T, Eriksson L, Greitz T, Johnström P, Litton JE, Nilsson JL, Sedvall G, Stone-Elander S. Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. The International Journal of Applied Radiation and Isotopes. 36: 269-73. PMID 3874833 DOI: 10.1016/0020-708X(85)90083-3 |
0.619 |
|
| 1985 |
Farde L, Ehrin E, Eriksson L, Greitz T, Hall H, Hedström CG, Litton JE, Sedvall G. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 82: 3863-7. PMID 3873656 DOI: 10.1073/PNAS.82.11.3863 |
0.632 |
|
| 1985 |
Persson A, Ehrin E, Eriksson L, Farde L, Hedström CG, Litton JE, Mindus P, Sedvall G. Imaging of [11C]-labelled Ro 15-1788 binding to benzodiazepine receptors in the human brain by positron emission tomography. Journal of Psychiatric Research. 19: 609-22. PMID 3001301 DOI: 10.1016/0022-3956(85)90080-9 |
0.578 |
|
| 1985 |
Bjerkenstedt L, Edman G, Hagenfeldt L, Sedvall G, Wiesel FA. Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controls. The British Journal of Psychiatry : the Journal of Mental Science. 147: 276-82. PMID 2415198 DOI: 10.1192/Bjp.147.3.276 |
0.356 |
|
| 1984 |
Oxenstierna G, Bergstrand G, Bjerkenstedt L, Sedvall G, Wik G. Evidence of disturbed CSF circulation and brain atrophy in cases of schizophrenic psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 144: 654-61. PMID 6743934 DOI: 10.1192/Bjp.144.6.654 |
0.308 |
|
| 1984 |
Widén L, Blomqvist G, DePaulis T, Ehrin E, Eriksson L, Farde L, Greitz T, Hedström CG, Ingvar DH, Litton JE, Nilsson JL, Ögren SO, Sedvall G, Stone-Slander S, Wiesel F-, et al. STUDIES OF SCHIZOPHRENIA WITH POSITRON CT Clinical Neuropharmacology. 7: S295. DOI: 10.1097/00002826-198406001-00266 |
0.466 |
|
| 1983 |
Nybäck H, Berggren BM, Hindmarsh T, Sedvall G, Wiesel FA. Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteers. Psychiatry Research. 9: 301-8. PMID 6196802 DOI: 10.1016/0165-1781(83)90003-3 |
0.322 |
|
| 1983 |
Borg S, Kvande H, Sedvall G. Monoamine Metabolites In Lumbar Cerebrospinal Fluid And Urine In Alcoholic Patients Before And After Treatment With Disulfiram Alcohol and Alcoholism. 18: 61-65. DOI: 10.1093/Oxfordjournals.Alcalc.A044338 |
0.322 |
|
| 1982 |
Wiesel FA, Alfredsson G, Ehrnebo M, Sedvall G. Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations. Psychopharmacology. 76: 44-7. PMID 6805007 DOI: 10.1007/Bf00430753 |
0.32 |
|
| 1978 |
Lindholm H, Gullberg B, Ohman A, Sedvall G. Effects of perphenazine enanthate injections on prolactin levels in plasma from schizophrenic women and men. Psychopharmacology. 57: 1-4. PMID 96459 DOI: 10.1007/Bf00426949 |
0.302 |
|
| 1978 |
Sedvall G, Bjerkenstedt L, Lindström L, Wode-Helgodt B. Clinical assessment of dopamine receptor blockade. Life Sciences. 23: 425-9. PMID 29184 DOI: 10.1016/0024-3205(78)90147-9 |
0.422 |
|
| 1977 |
Wode-Helgodt B, Fyrö B, Gullberg B, Sedvall G. Effect of chlorpromazine treatment on monoamine metabolite levels in cerebrospinal fluid of psychotic patients. Acta Psychiatrica Scandinavica. 56: 129-42. PMID 899844 DOI: 10.1111/J.1600-0447.1977.Tb06671.X |
0.334 |
|
| 1977 |
Bjerkenstedt L, Gullberg B, Härnryd C, Sedvall G. Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene. Archiv Fã¼R Psychiatrie Und Nervenkrankheiten. 224: 107-18. PMID 21644 DOI: 10.1007/Bf00346479 |
0.367 |
|
| 1976 |
Swahn C-G, Sandgárde B, Wiesel F-A, Sedvall G. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method. Psychopharmacology. 48: 147-53. PMID 826926 DOI: 10.1007/Bf00423253 |
0.306 |
|
| 1976 |
Nyback H, Sedvall G. Effects of neuroleptics on striatal dopamine synthesized from 14C-tyrosine. Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology. 2: 49-63. PMID 772722 DOI: 10.1016/0306-039X(76)90018-0 |
0.397 |
|
| 1975 |
Sedvall G. A relation between drug concentrations in brain and striatal homovanillic acid levels in chlorpromazine treated rats. Life Sciences. 16: 1145-55. PMID 1134188 DOI: 10.1016/0024-3205(75)90198-8 |
0.315 |
|
| 1975 |
Wiesel FA, Sedvall G. Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat. European Journal of Pharmacology. 30: 364-7. PMID 236193 DOI: 10.1016/0014-2999(75)90123-5 |
0.314 |
|
| 1974 |
Fyrö B, Wode-Helgodt B, Borg S, Sedvall G. The effect of chlorpromazine on homovanillic acid levels in cerebrospinal fluid of schizophrenic patients. Psychopharmacologia. 35: 287-94. PMID 4831513 DOI: 10.1007/Bf00429219 |
0.36 |
|
| 1974 |
Sedvall G, Fyrö B, Nybäck H, Wiesel FA, Wode-Helgodt B. Mass fragmentometric determination of homovanillic acid in lumbar cerebrospinal fluid of schizophrenic patients during treatment with antipsychotic drugs. Journal of Psychiatric Research. 11: 75-80. PMID 4461807 DOI: 10.1016/0022-3956(74)90075-2 |
0.453 |
|
| 1974 |
Wiesel FA, Sedvall G. Post-mortal changes of dopamine and homovanillic acid levels in rat striatum as measured by mass fragmentography. Brain Research. 65: 547-50. PMID 4415145 DOI: 10.1016/0006-8993(74)90247-9 |
0.328 |
|
| 1973 |
Wiesel FA, Fri CG, Sedvall G. Determination of homovanillic acid turnover in rat striatum using a monoamine oxidase inhibitor. European Journal of Pharmacology. 23: 104-6. PMID 4733765 DOI: 10.1016/0014-2999(73)90250-1 |
0.313 |
|
| 1973 |
Mayevsky A, Sjöquist B, Fri CG, Samuel D, Sedvall G. Incorporation of 18 O into homovanillic acid of rat brain during exposure to oxygen 18 containing atmospheres. Biochemical and Biophysical Research Communications. 51: 746-55. PMID 4704058 DOI: 10.1016/0006-291X(73)91379-X |
0.306 |
|
| 1973 |
Sjöquist B, Dailey J, Sedvall G, Anggård E. Mass fragmentographic assay of homovanillic acid in brain tissue. Journal of Neurochemistry. 20: 729-33. PMID 4703787 DOI: 10.1111/j.1471-4159.1973.tb00033.x |
0.34 |
|
| 1972 |
Nybäck H, Sedvall G. Effect of chlorpromazine and some of its metabolites on synthesis and turnover of catecholamines formed from 14 C-tyrosine in mouse brain. Psychopharmacologia. 26: 155-60. PMID 5073041 DOI: 10.1007/Bf00422102 |
0.454 |
|
| 1972 |
Fyrö B, Nybäck H, Sedvall G. Tyrosine hydroxylation in the rat striatum in vitro and in vivo after nigral lesion and chlorpromazine treatment. Neuropharmacology. 11: 531-7. PMID 4403078 DOI: 10.1016/0028-3908(72)90008-1 |
0.385 |
|
| 1972 |
Schubert J, Sedvall G. Effect of amphetamines on tryptophan concentrations in mice and rats. The Journal of Pharmacy and Pharmacology. 24: 53-62. PMID 4401317 DOI: 10.1111/J.2042-7158.1972.Tb08864.X |
0.308 |
|
| 1971 |
Nybäck H, Sedvall G. Effect of nigral lesion on chlorpromazine-induced acceleration of dopamine synthesis from [14C]tyrosine. Journal of Pharmacy and Pharmacology. 23: 322-326. PMID 4397399 DOI: 10.1111/J.2042-7158.1971.Tb09921.X |
0.396 |
|
| 1970 |
Nybäck H, Sedvall G. Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues. European Journal of Pharmacology. 10: 193-205. PMID 5446375 DOI: 10.1016/0014-2999(70)90273-6 |
0.391 |
|
| 1970 |
Nybäck H, Schubert J, Sedvall G. Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain. The Journal of Pharmacy and Pharmacology. 22: 622-4. PMID 4394540 DOI: 10.1111/J.2042-7158.1970.Tb10583.X |
0.328 |
|
| 1969 |
Nybäck H, Sedvall G. Regional accumulation of catecholamines formed from tyrosine-14C in rat brain: effect of chlorpromazine. European Journal of Pharmacology. 5: 245-52. PMID 5772674 DOI: 10.1016/0014-2999(69)90145-9 |
0.42 |
|
| 1968 |
Nybäck H, Borzecki Z, Sedvall G. Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs. European Journal of Pharmacology. 4: 395-403. PMID 5724916 DOI: 10.1016/0014-2999(68)90025-3 |
0.403 |
|
| 1967 |
Ngai SH, Rosell S, Sedvall G. Influence of hypercapnia on the noradrenalin content of sympathetically decentralized and innervated skeletal muscle. Experientia. 23: 394-5. PMID 6065787 |
0.401 |
|
| 1966 |
Fredholm B, Sedvall G. Influence of sympathetic nerve stimulation on noradrenaline stores in the rat salivary gland Life Sciences. 5: 2023-2032. DOI: 10.1016/0024-3205(66)90275-X |
0.435 |
|
| 1963 |
ROSELL S, SEDVALL G, ULLBERG S. Distribution and fate of dihydroxyphenylalanine-2-14C (DOPA) in mice. Biochemical Pharmacology. 12: 265-9. PMID 13974812 DOI: 10.1016/0006-2952(63)90149-7 |
0.565 |
|
| 1962 |
ROSELL S, SEDVALL G. The rate of disappearance of vasoconstrictor responses to sympathetic chain stimulation after reserpine treatment. Acta Physiologica Scandinavica. 56: 306-14. PMID 13974811 DOI: 10.1111/j.1748-1716.1962.tb02507.x |
0.481 |
|
| 1961 |
ROSELL S, SEDVALL G. Restoration of vasoconstrictor effects in reserpinized cats. Acta Physiologica Scandinavica. 53: 174-84. PMID 14493858 DOI: 10.1111/j.1748-1716.1961.tb02275.x |
0.567 |
|
| 1961 |
Rosell S, Sedvall G. 205 Quantitative aspects of the restoration of vasoconstrictor effects in reserpinized cats Biochemical Pharmacology. 8: 63-64. DOI: 10.1016/0006-2952(61)90383-5 |
0.417 |
|
| Show low-probability matches. |
